Lagarde Michel's Form 4 filing
Thermo Fisher Scientific Inc. (TMO) · filed May 31, 2022
- Accession no.
- 0001127602-22-016032
- Filed
- May 31, 2022
- Trade date
- May 26-27, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $16.3M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lagarde MichelCIK 0001518973 | Officer (Executive Vice President & COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | Common Stock | MOption exerciseAcquired | +6,049 | $210.68 | +$1,274,403.32 | 21,807.21 | Direct | |
| May 26, 2022 | Common Stock | MOption exerciseAcquired | +10,715 | $253.99 | +$2,721,502.85 | 32,522.21 | Direct | |
| May 26, 2022 | Common Stock | SSaleDisposed | −7,542 | $535.38F1 | −$4,037,835.96 | 24,980.21 | Direct | |
| May 26, 2022 | Common Stock | SSaleDisposed | −7,083 | $536.25F2 | −$3,798,258.75 | 17,897.21 | Direct | |
| May 26, 2022 | Common Stock | SSaleDisposed | −2,139 | $537.40F3 | −$1,149,498.6 | 15,758.21 | Direct | |
| May 27, 2022 | Common Stock | MOption exerciseAcquired | +9,137 | $309.63 | +$2,829,089.31 | 24,895.21 | Direct | |
| May 27, 2022 | Common Stock | MOption exerciseAcquired | +3,893 | $458.81 | +$1,786,147.33 | 28,788.21 | Direct | |
| May 27, 2022 | Common Stock | SSaleDisposed | −3,117 | $564.23F4 | −$1,758,704.91 | 25,671.21 | Direct | |
| May 27, 2022 | Common Stock | SSaleDisposed | −8,731 | $565.18F5 | −$4,934,586.58 | 16,940.21 | Direct | |
| May 27, 2022 | Common Stock | SSaleDisposed | −1,182 | $566.16F6 | −$669,201.12 | 15,758.21 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | Common Stock | MOption exerciseDisposed | −10,715 | $0.00 | $0 | 4,638 | Direct | |
| May 26, 2022 | Common Stock | MOption exerciseDisposed | −6,049 | $0.00 | $0 | 0 | Direct | |
| May 27, 2022 | Common Stock | MOption exerciseDisposed | −3,893 | $0.00 | $0 | 11,682 | Direct | |
| May 27, 2022 | Common Stock | MOption exerciseDisposed | −9,137 | $0.00 | $0 | 9,138 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.86 to $535.85, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), and (6) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.86 to $536.85, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.86 to $537.59, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.695 to $564.69, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.70 to $565.69, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $565.815 to $566.71, inclusive.
Referenced by the price of 1 transaction in Table I.